Patients with carotid artery plaque in which MNPs were detected had a higher risk of a composite of myocardial infarction, stroke, or death from any cause at 34 months of follow-up than those in whom MNPs were not detected.
An assessment of the current state of microfluidic technologies for lipid-based nanoparticle and nanomedicine production is presented, with an emphasis on the capabilities of microfluidic systems for controlling nanoparticle size and size distribution.
Article Galaxy Pages is a free service from Research Solutions, a company that offers access to content in collaboration with publishing partners, online repositories and discovery services.